Association of MMP-3 5A/6A and NOS3 G894T polymorphisms with hypertension and serum hdl cholesterol level
Нема приказа
Аутори
Đurić, TamaraŽivković, Maja
Mečanin, Sanja
Caranovic, O
Stanković, Aleksandra
Alavantić, Dragan
Конференцијски прилог
Метаподаци
Приказ свих података о документуИзвор:
Atherosclerosis Supplements, 2005, 6, 1, 17-18Напомена:
- 75th Congress of the European-Atherosclerosis-Society, Apr 23-26, 2005, Prague, Czech Republic
Колекције
Институција/група
VinčaTY - CONF AU - Đurić, Tamara AU - Živković, Maja AU - Mečanin, Sanja AU - Caranovic, O AU - Stanković, Aleksandra AU - Alavantić, Dragan PY - 2005 UR - https://vinar.vin.bg.ac.rs/handle/123456789/6504 C3 - Atherosclerosis Supplements T1 - Association of MMP-3 5A/6A and NOS3 G894T polymorphisms with hypertension and serum hdl cholesterol level VL - 6 IS - 1 SP - 17 EP - 18 DO - 10.1016/S1567-5688(05)80067-4 ER -
@conference{ author = "Đurić, Tamara and Živković, Maja and Mečanin, Sanja and Caranovic, O and Stanković, Aleksandra and Alavantić, Dragan", year = "2005", journal = "Atherosclerosis Supplements", title = "Association of MMP-3 5A/6A and NOS3 G894T polymorphisms with hypertension and serum hdl cholesterol level", volume = "6", number = "1", pages = "17-18", doi = "10.1016/S1567-5688(05)80067-4" }
Đurić, T., Živković, M., Mečanin, S., Caranovic, O., Stanković, A.,& Alavantić, D.. (2005). Association of MMP-3 5A/6A and NOS3 G894T polymorphisms with hypertension and serum hdl cholesterol level. in Atherosclerosis Supplements, 6(1), 17-18. https://doi.org/10.1016/S1567-5688(05)80067-4
Đurić T, Živković M, Mečanin S, Caranovic O, Stanković A, Alavantić D. Association of MMP-3 5A/6A and NOS3 G894T polymorphisms with hypertension and serum hdl cholesterol level. in Atherosclerosis Supplements. 2005;6(1):17-18. doi:10.1016/S1567-5688(05)80067-4 .
Đurić, Tamara, Živković, Maja, Mečanin, Sanja, Caranovic, O, Stanković, Aleksandra, Alavantić, Dragan, "Association of MMP-3 5A/6A and NOS3 G894T polymorphisms with hypertension and serum hdl cholesterol level" in Atherosclerosis Supplements, 6, no. 1 (2005):17-18, https://doi.org/10.1016/S1567-5688(05)80067-4 . .